In 2013, the American College of Cardiology and the AmericanHeart Association (ACC/AHA) published new guidelines for assessing cardiovascular disease (CVD) risk1 and for treatment of blood cholesterol to reduce CVD.2 These new guidelines replaced the Adult TreatmentPanel III (ATPIII)guidelines for thedetection,evaluation, and treatment of high blood cholesterol3 that guidedclinical practice for...

The metabolic syndrome, clinically defined by the Adult Treatment Panel III (ATPIII) (1), affects 25% of western adults (2). The metabolic syndrome is closely linked to insulin resist ance and impl i e s an increased cardiovascular risk (3,4). Accumulating evidence suggests a link between body iron excess and insulin metabolism (5). Studies have shown an association between serum ferritin and o...

Metabolic syndrome is highly prevalent in type 2 diabetics and is a strong risk factor for cardiovascular diseases in such patients. The aim of this study was to determine the prevalence of metabolic syndrome according to the three criteria of ATPIII, IDF and the new criteria for metabolic syndrome diagnosis in Kerman, Iran. This cross-sectional study was performed on 950 diabetic type 2 patien...

This study was performed to investigate the prevalence of the metabolic syndrome using a large representative sample in Beijing. Data from a total of 16442 adults (6489 men and 9953 women) aged > or =18 years from a survey of behavioral risk factors for chronic diseases in Beijing, in 2005, was analyzed. The prevalence of the metabolic syndrome increased with age and the age-standardized preval...

OBJECTIVES Describe the prevalence of metabolic syndrome, and its association with contemporary lifestyle factors. SUBJECTS AND METHODS In 2004-2005, 4,296 subjects of the 1982 Pelotas Birth Cohort were evaluated, and metabolic syndrome (MetS) was assessed in 3,599 according to the NCEP-ATP III and IDF criteria. RESULTS Prevalence of MetS was 5.9% and 6.7% for NCEP-ATPIII and IDF, respectiv...

Metabolic syndrome (MetS) is a primary risk factor for cardiovascular disease and is associated with a proinflammatory state. Here, we assessed the contribution of inflammatory and oxidative stress markers towards prediction of MetS. A total of 2316 individuals were recruited in Phase I of the Indian Atherosclerosis Research Study (IARS). Modified ATPIII guidelines were used for classification ...

OBJECTIVE To analyze the participation of fatty liver (FL) in the association of metabolic syndrome (MS) with type 2 diabetes and coronary artery calcification (CAC). RESEARCH DESIGN AND METHODS A total of 765 subjects (52% women) aged 30 to 75 years without clinical atherosclerosis were included in this study. MS was defined in accordance with the Adult Treatment Panel III (ATPIII) guideline...